1. Home
  2. BHVN vs NEO Comparison

BHVN vs NEO Comparison

Compare BHVN & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.39

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.52

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHVN
NEO
Founded
2013
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
BHVN
NEO
Price
$11.39
$9.52
Analyst Decision
Buy
Strong Buy
Analyst Count
14
8
Target Price
$29.08
$13.38
AVG Volume (30 Days)
1.7M
1.9M
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
26.08
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.63
Revenue Next Year
N/A
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.48
$4.72
52 Week High
$18.57
$13.74

Technical Indicators

Market Signals
Indicator
BHVN
NEO
Relative Strength Index (RSI) 68.12 64.91
Support Level $10.75 $9.35
Resistance Level $11.92 $10.82
Average True Range (ATR) 0.66 0.39
MACD 0.20 0.08
Stochastic Oscillator 99.48 97.19

Price Performance

Historical Comparison
BHVN
NEO

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: